NCT04962633

Brief Summary

This study aims to investigate the effects of daily consumption for 4 weeks of a probiotic durum wheat pasta vs a conventional durum wheat pasta without probiotics on fasting metabolic parameters and inflammatory status, on gut permeability and functionality, on daily energy intakes, appetite feelings, body weight, body mass index (BMI), waist and hip circumferences, blood pressure, body composition and wellbeing status in overweight and obese subjects.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 10, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

July 15, 2021

Completed
6 months until next milestone

Study Start

First participant enrolled

January 1, 2022

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 23, 2022

Completed
8 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
Last Updated

February 17, 2023

Status Verified

February 1, 2023

Enrollment Period

12 months

First QC Date

June 10, 2021

Last Update Submit

February 16, 2023

Conditions

Outcome Measures

Primary Outcomes (3)

  • Changes in fasting inflammatory blood markers

    Measure of plasma C-reactive protein (mmol/L)

    1 months

  • Changes in fasting plasma lipids

    Measure of plasma concentrations (mg/dL) of Total-, LDL-, and HDL-Cholesterol, as well as Triglycerides

    1 months

  • Changes in fasting plasma glucose

    Measure of plasma glucose concentrations (mg/dL)

    1 months

Secondary Outcomes (25)

  • Changes in small intestine permeability

    1 month

  • Changes in colonic permeability

    1 month

  • Changes in stool consistency

    1 month

  • Changes in stool weight

    1 month

  • Changes in stool frequency

    1 month

  • +20 more secondary outcomes

Study Arms (2)

Probiotic Pasta Group

EXPERIMENTAL

Subjects in the Probiotic Pasta group will consume 80 g per day of a probiotic pasta for 4 weeks

Other: Probiotic Pasta

Control Pasta Group

ACTIVE COMPARATOR

Control Pasta Subjects in the Control Pasta group will consume 80 g per day of conventional pasta for 4 weeks.

Other: Control Pasta

Interventions

Subjects will consume for 4 weeks 80 g per day of probiotic durum wheat pasta. All subjects will be requested not to change the other daily dietary habits and their physical activity levels during the 4 week intervention period.

Probiotic Pasta Group

Subjects will consume for 4 weeks 80 g per day of conventional durum wheat pasta without probiotics. All subjects will be requested not to change the other daily dietary habits and their physical activity levels during the 4 week intervention period.

Control Pasta Group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • healthy subjects;
  • men and women;
  • age 18-65 years;
  • kg/m2 ≤ BMI ≤ 35 kg/m2;
  • habitual daily pasta consumption (≥ 1 portion/day);
  • habitual diet characterized by absence of any food supplements and alternative medication, probiotics and prebiotics, whole grain and/or fiber enriched foods;
  • intake of fruit/vegetables \< 3 servings/day;
  • low level of physical activity (\< 500 metabolic equivalent min/week);
  • signed written informed consent.

You may not qualify if:

  • food allergies and intolerances and celiac disease;
  • gastrointestinal diseases;
  • relevant diseases;
  • pregnant or breastfeeding;
  • previous abdominal surgery;
  • hypertriglyceridemia (Triglycerides \> 200 mg/dL);
  • hypercholesterolemia (Total cholesterol \> 200 mg/dL);
  • hyperglycaemia (glycaemia ≥ 110 mg/dL);
  • hypertension (arterial blood pressure ≥140/90 mm Hg);
  • weight loss ≥ 3 kg within 2 months before the study;
  • antibiotics treatment within 3 months before the study;
  • any medication (different from antibiotics) at the enrollment and within 2 months before the study;
  • habitual diet characterized by high fruit and vegetables intakes (\>3 portion/die);
  • high level of physical activity;
  • Alcohol consumption ≥ 3 alcohol units per day;
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Agricultural Sciences

Portici, 80055, Italy

Location

MeSH Terms

Conditions

OverweightObesity

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Paola Vitaglione, Professor

    Department of Agricultural Sciences, Federico II University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

June 10, 2021

First Posted

July 15, 2021

Study Start

January 1, 2022

Primary Completion

December 23, 2022

Study Completion

December 31, 2022

Last Updated

February 17, 2023

Record last verified: 2023-02

Locations